Petraschka M, et al. (2007) The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation. Neuroscience 146, 1795-807 17467916

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

T180-p - MOR-1 (mouse) ▲

Modsite: VKALDFRtPRNAKIV SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): T182‑p, MOR‑1 iso5 (human): T182‑p, MOR‑1 (mouse): T180‑p, MOR‑1 (rat): T180‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  pituitary cancer Relevant cell lines - cell types - tissues:  'brain, striatum', 293 (epithelial), AtT20 (pituitary cell) Cellular systems studied:  cell lines, tissue Species studied:  human, mouse

T370-p - MOR-1 (mouse) ▲

Modsite: sARIRQNtREHPstA SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): T372‑p, MOR‑1 iso5 (human): T372‑p, MOR‑1 (mouse): T370‑p, MOR‑1 (rat): T370‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  pituitary cancer Relevant cell lines - cell types - tissues:  'brain, striatum', 293 (epithelial), AtT20 (pituitary cell) Cellular systems studied:  cell lines, tissue Species studied:  human, mouse Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes fentanyl increase naloxone fentanyl inhibit treatment-induced increase no inhibition in beta-endorphin homozygous null painful stimulus increase no increase in beta-endorphin homozygous null

S375-p - MOR-1 (mouse) ▲

Modsite: QNtREHPstANtVDR SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): S377‑p, MOR‑1 iso5 (human): S377‑p, MOR‑1 (mouse): S375‑p, MOR‑1 (rat): S375‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  pituitary cancer Relevant cell lines - cell types - tissues:  'brain, striatum', 293 (epithelial), AtT20 (pituitary cell) Cellular systems studied:  cell lines, tissue Species studied:  human, mouse Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes fentanyl increase naloxone fentanyl inhibit treatment-induced increase no inhibition in beta-endorphin homozygous null painful stimulus increase no increase in beta-endorphin homozygous null

T180-p - MOR-1 (rat) ▲

Modsite: VKALDFRtPRNAKIV SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): T182‑p, MOR‑1 iso5 (human): T182‑p, MOR‑1 (mouse): T180‑p, MOR‑1 (rat): T180‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  pituitary cancer Relevant cell lines - cell types - tissues:  'brain, striatum', 293 (epithelial), AtT20 (pituitary cell) Cellular systems studied:  cell lines, tissue Species studied:  human, mouse Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes DAMGO no change compared to control

T370-p - MOR-1 (rat) ▲

Modsite: sTRVRQNtREHPsTA SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): T372‑p, MOR‑1 iso5 (human): T372‑p, MOR‑1 (mouse): T370‑p, MOR‑1 (rat): T370‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  pituitary cancer Relevant cell lines - cell types - tissues:  'brain, striatum', 293 (epithelial), AtT20 (pituitary cell) Cellular systems studied:  cell lines, tissue Species studied:  human, mouse Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes DAMGO increase naloxone DAMGO inhibit treatment-induced increase

S375-p - MOR-1 (rat) ▲

Modsite: QNtREHPsTANTVDR SwissProt Entrez-Gene Orthologous residues MOR‑1 (human): S377‑p, MOR‑1 iso5 (human): S377‑p, MOR‑1 (mouse): S375‑p, MOR‑1 (rat): S375‑p Characterization Methods used to characterize site in vivo:  mutation of modification site, phospho-antibody, western blotting Disease tissue studied:  pituitary cancer Relevant cell lines - cell types - tissues:  'brain, striatum', 293 (epithelial), AtT20 (pituitary cell) Cellular systems studied:  cell lines, tissue Species studied:  human, mouse Upstream Regulation Treatments, proteins and their effect on site modification:  Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes DAMGO increase naloxone DAMGO inhibit treatment-induced increase